Prelude Therapeutics Incorporated (PRLD) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts PRLD Hot Sheet
Join SI Premium – FREE
Prelude Therapeutics Incorporated (NASDAQ: PRLD) reported Q1 EPS of ($0.42), $0.07 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Prelude Therapeutics Incorporated (PRLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
